KFP
PJP icon

Kroeger Financial Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Kroeger Financial Partners’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6K Buy
+284
New +$30.7K 0.03% 88

Other funds holding PJP

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
WTC
WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
SWGC
Summit Wealth Group (Colorado) Colorado Springs, Colorado $1.21B AUM 33.48% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.48B AUM 21.26% 1-Year Est. Return

Kroeger Financial Partners's PJP Position: Q2 2026 in Review

Kroeger Financial Partners opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q2 2026: 284 shares worth $33.6K. The stake represents 0.03% of the portfolio and ranks #88 among its holdings.

37 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Kroeger Financial Partners held 284 shares of Invesco Pharmaceuticals ETF worth $33.6K as of Q2 2026.
  • Invesco Pharmaceuticals ETF was a new Kroeger Financial Partners position in Q2 2026.
  • Invesco Pharmaceuticals ETF made up 0.03% of Kroeger Financial Partners's portfolio in Q2 2026, its #88 holding.
  • 37 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Kroeger Financial Partners's 13F filing for Q2 2026, filed 27 Jul 2026.